Difference between revisions of "Pharm Meeting Agenda 2021.03.17"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
|||
| Line 12: | Line 12: | ||
===Change Proposals === | ===Change Proposals === | ||
| + | :* CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles | ||
| + | :* CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile) | ||
| + | :* CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | ||
| + | :* CP-PHARM-145 Cross-community PHARM-1 (CMPD profile) | ||
| + | :* CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile) | ||
| + | :* CP-PHARM-147 moodCode for patient-reported medications (MTP profile) | ||
=== Medication lists === | === Medication lists === | ||
Revision as of 08:49, 10 March 2021
Meeting details
Location
Agenda
Q1 13:00- 14:30 Change proposals & Medication Lists
Change Proposals
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
- CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
- CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
- CP-PHARM-147 moodCode for patient-reported medications (MTP profile)